CoChat

Chromogranin As a Biochemical Marker of Neuroendocrine Tumors

Lyubimova, N. V., Churikova, T. K., Kushlinskii, N. E. · 2016 · Bulletin of Experimental Biology and Medicine

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Comparative study of plasma chromogranin A levels was carried out in 227 patients with neuroendocrine tumors of various locations and 66 normal subjects, men and women, by standard ELISA. In patients with tumors of all locations (pancreas, stomach, small and large intestine, and lungs), the glycoprotein levels were significantly (p<0.000001) higher than in controls. The patients demonstrated high variability of chromogranin A levels; the maximum concentrations were detected in patients with neuroendocrine tumors of the stomach and lung. The highest median values of chromogranin A were found in patients with tumors of the small intestine, large intestine, and pancreas. A relationship between secretion of chromogranin A and dissemination and activity of the neuroendocrine tumor was detected, which was the maximum in patients with metastases in the liver and carcinoid syndrome. High diagnostic sensitivity of chromogranin A was shown: 85.8% for the total group of patients; specificity was 98.5%. These data confirmed high efficiency of chromogranin A as the marker of neuroendocrine tumors. Detection of this marker promotes more accurate diagnosis and evaluation of dissemination of the neuroendocrine tumors.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10517-016-3254-0

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 9 references

Research works printed but not linked: 1

  1. N. V. Lyubimova and N. E. Kushlinskii, Vopr. Biol. Med. Farm. Khim., 12, No. 1, 48-58 (2014).

Cited by

See all 20

Metadata

Authors
Lyubimova, N. V., Churikova, T. K., & Kushlinskii, N. E.
Affiliations
Russian Cancer Research Center NN Blokhin (RU)
Corresponding author
Lyubimova, N. V.
Venue
Bulletin of Experimental Biology and Medicine
Published
2016-03
Volume
160
Issue
5
Pages
702-704
ISSN
  • 0007-4888 (ISSN-L)
  • 1573-8221
OpenAlex
W2316555918
Cited by
20
References
9
Citations by year
2026: 1 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 1 · 2017: 2
FWCI
1.56
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Bulletin of Experimental Biology and Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Medicine › Oncology › Neuroblastoma Research and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
chromogranin A, neuroendocrine tumors, tumor markers, sensitivity and specificity, carcinoid syndrome, liver metastasis, metastasis, pancreatic neuroendocrine tumors, gastric neuroendocrine tumor, small bowel neuroendocrine tumors, lung neuroendocrine tumors
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Sensitivity and Specificity, Biomarkers, Tumor, Neuroendocrine Tumors, Chromogranin A, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chromogranin As a Biochemical Marker of Neuroendocrine Tumors. https://app.cochat.ai/papers/10.1007/s10517-016-3254-0
The paper
Lyubimova, N. V., Churikova, T. K., & Kushlinskii, N. E. (2016). Chromogranin As a Biochemical Marker of Neuroendocrine Tumors. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-016-3254-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.